Accelmed Partners

About The Fund

Accelmed Partners is a venture capital fund based in the Azrieli Triangle Building, Tel Aviv, with an emphasis on equity investments within the healthcare technology sector. With assets under management amounting to $300 million, they target investments in medical devices and hospital services, among other specialized areas. As a firm, they engage in expansion and later-stage funding rounds, with a minimum investment threshold of $5 million. Their strategy involves taking a private equity approach to sectors that have been traditionally dominated by venture and early-stage growth firms. Accelmed Partners operates with a commitment to work closely with management teams, focusing on improving operations, updating product portfolios, and overhauling commercial organizations. Their support extends to providing resources essential for portfolio companies' success. Accelmed Partners is experienced in building market-leading companies in health technology and aims to help providers treat patients, enhance the efficiency of healthcare delivery, and expand patient access through tech-enabled services. The firm highlights a portfolio of leading healthcare technology innovations and claims active involvement in 21 portfolio companies, securing over 2000 employees worldwide. To date, they have made 7 AP-II Investments and achieved 9 successful exits, indicating a robust track record in the industry. Their sector focus also extends to tools & diagnostics to advance medicine and biology studies, as well as digital health solutions for more personalized and precise medicine.